S&P 및 Nasdaq 내재가치 문의하기

NovoCure Limited NVCR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • JE • USD

SharesGrow Score
51/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$33.50
+196.5%

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 NovoCure Limited (NVCR), 포함 26 건 매수21 건 매도. 내부자 매수 총액은 $9.91M 내부자 매도 총액은 $2.01M.

최근 활동이 있는 주요 내부자에는 Paravasthu Mukund, Weinberg Uri, Cordova Ashley. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — NVCR

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2026-03-05 Paravasthu Mukund Chief Operating Officer 정보 매도 43,246 $13.77 $595.67K 72,832
2026-03-04 Weinberg Uri Chf Medical and Innovation Ofr 정보 매도 6,412 $13.31 $85.31K 267,190
2026-03-04 Cordova Ashley Former Chief Executive Officer RSU 원천징수 17,638 $13.30 $234.59K 422,570
2026-03-04 Leonard Frank X Chief Executive Officer 정보 매도 5,607 $13.31 $74.6K 493,793
2026-03-04 Puri Michal Nath Chief Human Resources Officer 정보 매도 1,100 $13.31 $14.64K 201,322
2026-03-04 Leupin Nicolas Former Chief Medical Officer 정보 매도 1,100 $13.31 $14.64K 102,979
2026-03-04 Paravasthu Mukund Chief Operating Officer 정보 매도 5,377 $13.31 $71.54K 116,078
2026-03-04 Brackmann Christoph Chief Financial Officer 정보 매도 6,412 $13.31 $85.31K 182,842
2026-03-03 Doyle William F Executive Chairman RSU 부여 200,000 - - 200,000
2026-03-03 Weinberg Uri Chf Medical and Innovation Ofr RSU 부여 73,340 $13.30 $975.42K 73,340
2026-03-03 Leonard Frank X Chief Executive Officer RSU 부여 216,388 $13.30 $2.88M 216,388
2026-03-03 Ben Arye Barak General Counsel RSU 부여 73,340 $13.30 $975.42K 73,340
2026-03-03 Puri Michal Nath Chief Human Resources Officer RSU 부여 58,672 $13.30 $780.34K 58,672
2026-03-03 Paravasthu Mukund Chief Operating Officer RSU 부여 7,518 $13.30 $99.99K 7,518
2026-03-03 Brackmann Christoph Chief Financial Officer RSU 부여 80,674 $13.30 $1.07M 80,674
2026-03-02 Weinberg Uri Chf Medical and Innovation Ofr 정보 매도 3,272 $13.33 $43.61K 223,477
2026-03-02 Cordova Ashley Former Chief Executive Officer RSU 원천징수 7,228 $13.67 $98.81K 440,208
2026-03-02 Leonard Frank X Chief Executive Officer 정보 매도 7,232 $13.49 $97.58K 349,400
2026-02-28 Weinberg Uri Chf Medical and Innovation Ofr RSU 부여 12,992 - - 226,749
2026-02-28 Cordova Ashley Former Chief Executive Officer RSU 부여 23,818 - - 449,846
2026-02-28 Leonard Frank X Chief Executive Officer RSU 부여 18,621 - - 356,632
2026-02-28 Ben Arye Barak General Counsel RSU 부여 17,755 - - 192,328
2026-02-27 Weinberg Uri Chf Medical and Innovation Ofr 정보 매도 7,461 $13.84 $103.26K 213,757
2026-02-27 Cordova Ashley Former Chief Executive Officer RSU 원천징수 11,541 $13.75 $158.69K 426,028
2026-02-27 Leonard Frank X Chief Executive Officer 정보 매도 9,734 $13.66 $133K 338,011
2026-02-27 Puri Michal Nath Chief Human Resources Officer 정보 매도 1,441 $13.66 $19.69K 162,322
2026-01-11 Paravasthu Mukund Chief Operating Officer RSU 원천징수 2,133 $14.35 $30.61K 78,306
2025-12-31 Danziger Asaf Officer 알 수 없음 - - - -
2025-12-31 Ben Arye Barak Officer 알 수 없음 - - - -
2025-12-31 Puri Michal Nath Officer 알 수 없음 - - - -
2025-11-04 Paravasthu Mukund Chief Operating Officer RSU 원천징수 2,949 $12.23 $36.07K 80,439
2025-11-04 Brackmann Christoph Chief Financial Officer RSU 원천징수 7,033 $12.23 $86.01K 134,117
2025-11-01 Leonard Frank X EVP, Pres., Novocure Oncology RSU 원천징수 966 $12.81 $12.37K 347,745
2025-11-01 Paravasthu Mukund Chief Operating Officer RSU 원천징수 168 $12.81 $2.15K 83,388
2025-10-31 Puri Michal Nath Chief Human Resources Officer RSU 원천징수 752 $12.82 $9.64K 163,762
2025-09-05 Cordova Ashley Chief Executive Officer 정보 매수 81,550 $12.22 $996.86K 437,569
2025-07-29 Brackmann Christoph Chief Financial Officer 정보 매수 10,000 $11.63 $116.3K 131,150
2025-06-30 Danziger Asaf Director RSU 부여 833 $15.13 $12.6K 416,473
2025-06-30 Cordova Ashley Chief Executive Officer RSU 부여 833 $15.13 $12.6K 356,019
2025-06-30 Leonard Frank X EVP, Pres., Novocure Oncology RSU 부여 833 $15.13 $12.6K 348,711
2025-06-30 Ben Arye Barak General Counsel RSU 부여 769 $15.13 $11.63K 174,465
2025-06-30 Puri Michal Nath Chief Human Resources Officer RSU 부여 833 $15.13 $12.6K 164,514
2025-06-04 Hilleman Jeryl L Director RSU 부여 16,697 $16.72 $279.17K 16,697
2025-06-04 Leung Gabriel Director RSU 부여 16,697 $16.72 $279.17K 16,697
2025-06-04 Hung David Director RSU 부여 16,697 $16.72 $279.17K 16,697
2025-06-04 Vernon W Anthony Director RSU 부여 16,697 $16.72 $279.17K 16,697
2025-06-04 Scannell Timothy J Director RSU 부여 16,697 $16.72 $279.17K 16,697
2025-06-04 Madden Martin J. Director RSU 부여 33,393 $16.72 $558.33K 33,393
2025-06-04 Leonard Frank X EVP, Pres., Novocure Oncology RSU 부여 179,426 - - 347,878
2025-06-04 Ocean Allyson J Director RSU 부여 11,215 - - 14,269
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기